Cullinan Therapeutics, Inc.
CGEM
$8.71
$0.202.35%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.04% | -3.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.68% | -2.34% | |||
| Operating Income | -12.68% | 2.34% | |||
| Income Before Tax | -17.18% | 3.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.47% | 3.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.47% | 3.49% | |||
| EBIT | -12.68% | 2.34% | |||
| EBITDA | -12.69% | 2.34% | |||
| EPS Basic | -16.99% | 8.92% | |||
| Normalized Basic EPS | -16.71% | 8.93% | |||
| EPS Diluted | -16.99% | 8.92% | |||
| Normalized Diluted EPS | -16.71% | 8.93% | |||
| Average Basic Shares Outstanding | 0.42% | 5.97% | |||
| Average Diluted Shares Outstanding | 0.42% | 5.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
